SAN DIEGO — Adults with overweight or obesity lost up to 18.7% of their body weight at 46 weeks with a glucagon/GLP-1 dual agonist, according to a speaker.
In data from a phase 2 trial presented at the American Diabetes Association Scientific Sessions, survodutide (Boehringer Ingelheim and Zealand Pharma) induced a greater weight loss than placebo at 46 weeks, and most participants
Global Consumer Healthcare Market 2023-2027. The consumer healthcare market is forecasted to grow by USD 189.13 bn during 2022-2027, accelerating at a CAGR.
/PRNewswire/ The sexual enhancement supplements market size is forecast to increase by USD 835.06 million from 2022 to 2027, at a CAGR of 10.58%, according.
/PRNewswire/ The nutraceutical ingredients market size is expected to grow by USD 11.16 billion from 2022 to 2027 at a CAGR of 4.48% during the forecast.
/PRNewswire/ The global dietary supplements market size is estimated to increase by USD 61.4 billion from 2022 to 2027. The market s growth momentum will.